Dr. Reddys Laboratories Ltd.

BSE: 500124 | NSE: DRREDDY
Mid Cap | Pharmaceuticals & Drugs
1315.25
12.25 (0.94%)
< Home < Back

Dr. Reddy’s Laboratories reports 31% fall in Q2 consolidated net profit

Date: 26-10-2026

Dr. Reddy’s Laboratories has reported its results for the second quarter ended September 30, 2026 (Q2FY27).

The company has reported a 79.65% rise in its net profit at Rs 695.80 crore for the quarter ended September 30, 2026, as compared to Rs 387.30 crore for the same quarter in the previous year. Total income increased by 16.20% to Rs 5,789.90 crore for Q2FY27 as compared to Rs 4,982.80 crore for the corresponding quarter of the previous year.

On a consolidated basis, the company has reported a 31.35% fall in its net profit at Rs 924.80 crore for Q2FY27, as compared to Rs 1,347.10 crore for the same quarter in the previous year. Total income declined by 3.26% to Rs 8,854.00 crore for Q2FY27 as compared to Rs 9,152.20 crore for the corresponding quarter of the previous year.